BTG starts selling its products to European hospitals

1st Apr 2015 10:59

Healthcare company BTG said it started selling its drug-eluting bead and embolisation products to customers in 11 European countries.The products, DC Bead and Bead Block, will be sold directly to hospitals in Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Portugal, Switzerland, Spain, and the UK.Commercial officer John Sylvester said: "We're pleased to be supplying our beads and Therasphere products directly to healthcare professionals in Europe."BTG is investing in product innovation and clinical development to better serve specialist interventional oncology physicians."N+1 Singer analysts gave a 'hold' recommendation and said the deal "will highlight a strong roll-out of Varithena and good growth for the year. This could help to halt the recent negative performance of the shares, which are now trading 6% below our target price."Shares were up 2.26% to 731.18p on Wednesday at 11:33.